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Abstract 
 Helicobacter pylori is a gram negative gastric pathogen that infects the mucosal 
lining of the human stomach and is present is nearly half of the human population. H. 
pylori is the etiologic agent of peptic ulcer disease, and infection is highly associated with 
the development of gastric cancer. The H. pylori genome encodes three complete two-
component signal transduction systems (TCSTs): ArsRS, CrdRS, and FlgRS. Each 
system regulates many genes in response to environmental stimuli. The genome also 
encodes an essential orphan response regulator, HP1021. Previous transcriptional 
profiling experiments indicate that each of these TCSTs regulates the expression of 
virulence genes. The acetone carboxylase operon, acxABC, is associated with virulence 
and is regulated by all H. pylori TCSTs and HP1021. We characterized the TCST-
mediated transcriptional regulation of acxABC expression by examining the physical 
interaction of response regulators ArsR and HP1021, a repressor and activator of acxABC 
transcription, respectively, with the promoter region of acxA. Electrophoretic mobility 
shift assays suggest that both ArsR and HP1021 bind upstream and downstream of the     
-35 hexamer promoter element, with ArsR binding two distinct sites and HP1021 binding 
as many as six sites. All of the ArsR binding sites overlap with HP1021 binding sites, 
suggesting possible binding competition. Also, acxA expression was assayed via 
quantitative real-time PCR in H. pylori strains 26695 and J99 under both neutral and 
acidic conditions. Under neutral conditions, abrogation of arsS in H. pylori strain J99 
resulted in a 4.4-fold increase in acxA transcription, however no significant change in 
transcription was observed in strain 26695. Grown under acidic conditions, the J99 arsS 
null mutant exhibited approximately a 2.6-fold increase in acxA transcription with no 
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significant differential regulation occurring in the 26695 arsS null mutant. Collectively, 
this study suggests that H. pylori uses multiple TCSTs to regulate the expression of the 
acxABC operon, forming an overlapping regulatory network that allows finely tuned 
control over transcriptional regulation. This multi-layered mechanism of regulation may 
apply to other H. pylori virulence genes and represents a unique way for H. pylori, a 
bacterium with a relative paucity of TCSTs, to maintain tight control over gene 
expression. Inter-strain variation in the ArsRS-mediated regulation of acxA occurs 
between H. pylori strains J99 and 26695, offering the acxABC operon as a model for 
understanding strain-specific variation in TCST-mediated regulation of virulence factors. 
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1. Introduction 
1.1 - Helicobacter pylori 
 Helicobacter pylori is a gram negative bacterium that infects the human gastric 
mucosa. It has a characteristic helical shape as well as lophotrichous flagella at one pole. 
H. pylori was first isolated in 1982 by Drs. Barry Marshall and Robin Warren at the 
Royal Perth Hospital (Marshall & Warren, 1984). After its discovery, the association 
between H. pylori infection and the presence of gastric disease became increasingly clear 
(Dunn et al., 1997). Today, H. pylori is accepted as the primary causative agent of peptic 
ulcer disease and is also strongly associated with the development of gastric cancer. More 
than 90% of patients with duodenal ulcers and nearly 80% of gastric ulcer patients are 
colonized by Helicobacter pylori. Gastric cancer is the fourth most common cancer in the 
world, and rates of gastric cancer are twice as high in infected persons compared to those 
uninfected (Parkin, 2001; Vogiatizi et al., 2007).  
 Epidemiologically, H. pylori is one of the most widespread human pathogens, 
infecting approximately 50% of the human population around the world. In developing 
countries, incidence of infection approaches 70-90%, and in the developed world 20-30% 
infection rates are common (Dunn et al., 1997). However, only a fraction of those 
infected ever present overt symptoms, and symptoms usually appear during middle-age. 
A definitive route of transmission from individual to individual is not known, however 
most individuals are infected during childhood, and clustering of H. pylori strains occurs 
within families. This supports the hypothesis that H. pylori is transmitted between mother 
and child via an oral-oral or fecal-oral route through close contact (Brown, 2000; 
Vogiatzi et al., 2007). After infection, H. pylori is able to maintain a life-long, persistent 
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colonization of an individual. Much work has been done on treating patients infected with 
H. pylori, and many FDA-approved antibiotic regimens are employed today. The most 
common therapy involves a triple drug regimen with a proton pump inhibitor to lower the 
acidity of the stomach and facilitate clearance of the infection (Vogiatzi et al., 2007).  
 Due to its widespread infection rates, potential for intrafamilial transmission, and 
high mutation rate, H. pylori is highly genetically diverse. H. pylori also has a long 
history of infecting human beings. Genetic variation in H. pylori has been used as a 
marker to track human evolutionary history, a testament to the close association of the 
bacterium and mankind over the course of human evolution (McNulty et al., 2004; Wirth 
et al., 2004). Different strains of H. pylori cluster in various geographic areas, and some 
strains are more virulent than others. This has led to the observation of an interesting 
disconnect between infection rates and gastric disease incidence, first noted in Africa 
where infection with H. pylori is nearly universal but incidence of gastric disease is low 
(Holcombe, 1992). This contrasts with infected populations of East Asia, particularly in 
Japan and Korea, where infection rates are lower than Africa but rates of gastric 
adenocarcinoma are much higher (Miwa et al., 2002). This discordance is attributable to 
the highly variable pathogenicity of H. pylori strains as well as cultural, dietary, and life-
style factors. 
1.2 - Pathogenicity in Helicobacter pylori 
 H. pylori has a relatively small genome of ~1.7 million base pairs, and as such 
was the first bacterium to have two genetically distinct strains, 26695 and J99, fully 
sequenced (Tomb et al., 1997; Alm et al., 1999). After the discovery of H. pylori, many 
new strains were collected from patients suffering from gastric disease all over the world. 
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Large differences in the pathogenicity of these strains were noted, and genetic elements 
correlated to this difference in pathogenicity were identified and sequenced. One genetic 
element associated with more severe disease outcomes is the cytotoxin-associated genes 
pathogenicity island (cag-PAI), a 40-kb genomic insert containing 27-30 genes that codes 
for a Type IV Secretion System (T4SS), a needle-like appendage used by bacteria to 
translocate products into an adjacent cell (Wang et al., 2012). The most well-studied 
virulence factor encoded within the cag-PAI is CagA, a high molecular weight protein 
that is translocated via the T4SS into epithelial cells of the stomach. CagA+ strains 
induce more severe gastric inflammation via increased production of pro-inflammatory 
cytokines compared to cagA- strains (Blaser et al., 1995). Once inside the cell, CagA can 
be phosphorylated by human Abl and Src kinases and subsequently activates SHP-2, a 
eukaryotic tyrosine phosphatase. Sustained activation of SHP-2 disregulates multiple 
signaling pathways within human cells, leading to cellular instability and damage (Liu et 
al., 2012). In mice, direct transgenic expression of CagA induces hyperplasia in the 
gastric epithelium, ultimately resulting in cancer (Ohnishi et al., 2008). Both H. pylori 
strains used in this study, 26695 and J99, contain the cag-PAI and were isolated from 
patients suffering from gastric disease. Therefore these strains are associated with severe 
gastric disease and serve as excellent genetically tractable models for studying medically 
important molecular systems of H. pylori. 
 Other important virulence factors encoded by H. pylori include VacA, a 
vacuolating cytotoxin; urease, an enzyme responsible for catalyzing the hydrolysis of 
urea into carbon dioxide and ammonia; and SabA, an adhesin that that allows the 
bacterium to adhere to the sialyl-Lewisx antigen on gastric epithelial cells (Cover & 
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Blaser, 1992; Scott et al., 2002; Yamaoka et al., 2006). Virulence is not solely 
determined by bacterial virulence factors, but is influenced by host responses as well. 
Polymorphisms in epithelial cells that increase secretions of proinflammatory cytokines 
and decrease stomach acid secretion in response to H. pylori infection are also associated 
with more severe disease outcomes (El-Omar, 2001; Wroblewski et al., 2010). 
1.3 - Two-Component Signal Transduction 
 H. pylori resides in close association with the gastric mucosa and the gastric 
epithelium, a relatively restricted microbial niche adjacent to the highly variable 
environment of the stomach. Within this environment, H. pylori is exposed to a range of 
environmental stressors including fluctuating pH and metal ion concentrations. Some of 
the molecular mechanisms H. pylori uses to sense and respond to environmental changes 
are two-component signal transduction systems (TCSTs) (Beier & Frank, 2000). TCSTs 
are widespread conserved signal transduction systems present almost exclusively in 
prokaryotes. TCSTs are activated by environmental ligands and control a diverse range of 
cellular processes. TCSTs are generally composed of a transmembrane sensor histidine 
kinase protein and a cytoplasmic response regulator. Upon the binding of an 
environmental ligand to the histidine kinase, autophosphorylation occurs on a conserved 
histidine residue present on the cytosolic domain of the histidine kinase. This phosphoryl 
group is transferred to an aspartate residue in the N-terminal receiver domain of the 
cognate response regulator. Once phosphorylated, the response regulator alters its 
biological activity. Most TCSTs in bacteria function to alter gene expression in response 
to an external stimulus, however TCSTs are also capable of directly modifying the 
function of existing proteins (Bourret & Silversmith, 2010).  
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 In the canonical model, once the response regulator has been phosphorylated, a 
conformational change occurs in the protein that activates its C-terminal domain, also 
known as the output domain, which usually facilitates DNA binding (Figure 1) (Beier & 
Frank, 2000). The response regulator then interacts directly with its DNA targets, and all 
of the DNA targets of a particular response regulator are known as a “regulon.” A 
histidine kinase may not exclusively phosphorylate one response regulator. Instead, 
regulatory networks combining signaling between multiple histidine kinases and response 
regulators are prevalent. Understanding the mechanisms that govern this intricate 
molecular crosstalk is a challenge for researchers in the field, especially when some 
organisms maintain dozens of TCSTs operating in parallel. Small molecule phosphate 
donors such as acetyl phosphate are also capable of activating response regulators 
independently of histidine kinases, and many response regulators display inherent 
phosphorylation-independent activity (Bourret & Silversmith, 2010). These regulatory 
networks should not overshadow the detailed mechanisms governing regulatory 
specificity that exist as well (Laub & Goulian, 2007). Although sequence homology 
readily identifies new TCSTs, it is very difficult to surmise the environmental signal, 
regulon, or networking of a particular TCST from amino acid sequence alone. 
1.4 - Two-Component Signal Transduction in Helicobacter pylori 
 H. pylori encodes relatively few regulatory genes, with four histidine kinases and 
six response regulators identified through sequence analysis. Of these genes, three 
complete TCSTs involved in transcriptional regulation have been characterized: ArsRS 
(acid response system), CrdRS (copper resistance determinant), and FlgRS (flagellum-
based motility) (Beier & Frank, 2000). All three of the histidine kinases in these systems 
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are essential for colonization of a mouse model and thus control H. pylori virulence 
factors necessary for the establishment and maintenance of infection (Panthel et al., 
2003). Another system has been shown to serve as the functional equivalent of the 
CheA/CheY system in Escherichia coli that serves to directly control the activity of 
flagella (Beier et al., 1997). The additional two response regulators, HP1021 and HP1043, 
are identified as orphan response regulators because they do not have an apparent cognate 
histidine kinase (Mueller et al., 2007). H. pylori exhibits a relative paucity of TCST 
systems compared to other gram negative organisms, however obligate pathogens are 
often characterized by a small repertoire of transcriptional regulatory pathways that 
respond to common changes in the environment (Kim & Forst, 2001). One hypothesis for 
this phenomenon is that obligate pathogens colonize a narrow range of environments and 
thus devote fewer resources than free-living bacteria to responding to diverse conditions. 
In the case of H. pylori, it is restricted to one tissue type solely within human beings. 
While it resides in the challenging environment of the stomach, little competition from 
other microorganisms and a consistent set of environmental stressors warrant fewer 
TCSTs. A recent study of transcriptional regulatory networks in H. pylori concluded that 
the few genetic regulatory systems in H. pylori are densely interconnected with 
regulatory overlap between separate TCSTs. In this way, H. pylori is an excellent model 
system for studying TCST regulatory networking (Danielli et al., 2010). 
 TCSTs are also subject to the high degree of genetic variation existing between H. 
pylori strains. Each of the TCSTs in H. pylori involved in transcriptional regulation 
controls a discrete regulon of genes. Studies comparing the regulons of homologous 
TCSTs between various stains have noticed differences in regulon membership. An 
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example includes transcriptional profiling of the ArsRS regulon in strains 26695 and 
B128. By generating a null mutation in the arsS histidine kinase gene in both strains, 
macroarrays were used to identify genes that were differentially regulated between wild-
type and mutant strains. The regulons between 26695 and B128 matched entirely, but 
B128 showed upregulation of two additional genes, HP1408 and HP0427, that are found 
only in H. pylori (Forsyth et al., 2002). This and additional evidence of TCST inter-strain 
regulon variation from our lab make H. pylori an ideal candidate for studying strain-
specific gene regulation. 
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Figure 1. Conventional Paradigm for Two-Component Signal Transduction 
Systems. This diagram displays a TCST with only one histidine kinase that interacts with 
only one cognate response regulator. Other systems are possible, and response regulators 
may be capable of phosphorylation-independent activity as well. (A) The periplasmic 
domain of the histidine kinase detects an environmental signal. (B) Binding of the signal 
causes an ATP driven autophosphorylation event on cytoplasmic domains of the histidine 
kinase at conserved histidine residues. (C) Phosphotransfer of the phosphoryl group 
occurs from the histidine kinase histidine residue to an aspartate residue on the 
cytoplasmic response regulator. (D) The phosphorylated response regulator undergoes an 
allosteric change that allows binding of target DNA sequences and alters gene 
expression. (E) The response regulator is dephosphorylated. 
 
1.5 - The Acid Response System (ArsRS) Two-Component Signal Transduction 
System 
 ArsRS is currently the most well-studied TCST in H. pylori. The system is 
encoded by two adjacent genes, HP0166 and HP0165, and was first described in H. 
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pylori strain 26695. In this system, ArsS is the histidine kinase situated in the cytoplasmic 
membrane and undergoes autophosphorylation when environmental pH falls below 5.0. 
ArsR is the cytosolic response regulator with a C-terminal DNA-binding-domain and an 
N-terminal receiver domain where phosphotransfer occurs to the conserved aspartate 
residue. ArsR appears to exist as a monomer at biological concentrations (Gupta et al., 
2009). ArsR is capable of functioning both as a repressor and an activator of transcription, 
and it is an essential gene (Beier & Frank, 2000). Null mutants of arsS are tolerated while 
arsR null mutants are not viable. The ArsRS system stands for the Acid Response System 
and is primarily responsible for acid acclimation. Phosphorylated ArsR upregulates key 
acid adaptive genes such as those of the urease operon (Pflock et al., 2005). H. pylori is a 
neutrophile, thriving best near pH 7, but over the course of infection and persistent 
colonization the bacterium may be exposed to very low pH. One mechanism the 
bacterium uses to survive in acidic conditions is the expression of urease, which catalyzes 
the hydrolysis of urea to ammonia. This creates a neutral microenvironment around the 
bacterium, buffering it from the harsh conditions of the stomach lumen (Pflock et al., 
2006). One study confirmed the binding of ArsR in a region 60 bp upstream of the 
Pribnow box within the promoter of amiE, a gene upregulated under acidic conditions, 
however no consensus binding sequence has been identified (Pflock et al., 2006). 
 ArsRS does not only control the expression of acid adaptive genes. 
Unphosphorylated ArsR is capable of binding DNA, indicating the presence of another 
phosphorylation-independent regulon of genes essential for growth (Wen et al., 2006). 
Other genes regulated by phosphorylated ArsR do not depend on the presence of ArsS, 
indicating that ArsR may be phosphorylated through another mechanism. A review of H. 
	   10	  
pylori TCSTs describes an overlap between the regulon of phosphorylated ArsR and 
another TCST histidine kinase, FlgS, leading to the hypothesis that FlgS may be capable 
of phosphorylating ArsR in an example of regulatory overlap between distinct TCSTs 
(Danielli et al., 2010). In H. pylori strain J99, additional regulon overlap exists between 
ArsRS and CrdRS, the system responsible for regulating copper resistance genes (Loh et 
al., 2006). This overlap is not observed between H. pylori strains 26695 and G27, 
indicating the significance of inter-strain regulon variation as well as the difficulty of 
comparing studies when variable strains are used (Pflock et al., 2007a). 
1.6 - The Copper Resistance Determinant (CrdRS) Two-Component Signal 
Transduction System 
 CrdRS is encoded by histidine kinase CrdS (HP1364) and response regulator 
CrdR (HP1365). Based on sequence homology to known response regulators, CrdR 
appears to have an N-terminal receiver domain with a conserved aspartate 
phosphorylation site and a C-terminal DNA-binding domain. CrdRS has been 
characterized based on its role in copper resistance. The system is essential for 
upregulating the expression of CrdA, CrdB, and CzcB, a metal export system that exports 
intracellular copper. It is unclear whether H. pylori frequently encounters copper in its 
environment, but copper is also important in generating reactive-oxygen species in 
aqueous environments through Fenton reactions (Waidner et al., 2005). It is possible that 
the CrdRS system may be a more general regulator of the H. pylori response to oxidative 
stress in the stomach, but few studies exist that have explored the full CrdRS regulon. 
1.7 - The Flagellar FlgRS Two-Component Signal Transduction System 
 Functioning flagellar-motility is essential for the establishment of persistent 
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colonization of animal models by H. pylori (Eaton et al., 1996). FlgR (HP0703), the 
response regulator of the system, activates the transcription of five operons encoding the 
components of the flagella. These operons are controlled by a σ54 promoter, and FlgR 
only activates these genes in the presence of H. pylori or E. coli σ54 RNA polymerase. 
The C-terminus of FlgR is not predicted to be a DNA-binding domain, but instead shows 
homology with other σ54 RNA Polymerase activators. This makes FlgR unique among the 
response regulators encoded by H. pylori (Brahmachary et al., 2004). FlgS (HP0244), a 
histidine kinase, is predicted to localize to the cytoplasm, making it the only cytoplasmic 
histidine kinase in H. pylori. FlgS is also involved in the acid response as well as 
upregulating cagA, the important H. pylori virulence gene (Wen et al., 2009). The ligand 
that FlgS detects is poorly defined, but it is possible that FlgS acts as a sensor of cytosolic 
pH, much as ArsS senses extracellular pH (Wen et al., 2008). Mutant strains lacking 
FlgR do not form flagella, but they are capable of surviving at a lower pH than strains 
lacking FlgS. This supports the idea that any acid acclimation processes FlgS contributes 
to are effected by another response regulator.  
1.8 - The Orphan Response Regulator HP1021 
 HP1021, an orphan response regulator lacking a cognate histidine kinase, is an 
essential protein for normal growth in H. pylori. Mutations in hp1021 are tolerated, 
resulting in a highly growth-impaired phenotype (Schar et al., 2005). One of the reasons 
HP1021 is an essential protein is its role in upregulating the transcription of nifS and nifU, 
two housekeeping genes encoding nitrogenases. HP1021 functions as both a repressor 
and activator of transcription, and its regulon has been characterized through 
transcriptional profiling experiments (Pflock et al., 2007a). HP1021 contains a C-
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terminal DNA-binding domain but does not show homology to other DNA-binding 
domain families. The N-terminal region of the protein lacks the conserved aspartate 
residue required for activation of other response regulators, and mutations induced in this 
region have no effect on the growth of H. pylori (Beier & Frank, 2000). The transcription 
of HP1021 is upregulated under acidic conditions, however it does not belong to the 
regulons of H. pylori’s other acid responsive systems, ArsRS and FlgRS (Merrell et al., 
2003; Wen et al., 2003; Loh et al., 2010) One study investigating the importance of 
transcriptional control of HP1021 found that significantly increasing its expression had 
no detrimental impacts on cell growth (Mueller et al., 2006).  
1.9 - The Role of Two-Component Signal Transduction in Acetone Metabolism 
 Acetone, as well as acetoacetate and β-hydroxybutyrate, is one of the ketone 
bodies produced in liver tissue and secreted into the bloodstream during fatty acid 
metabolism. The process of ketogenesis occurs when glycogen stores in the liver are low, 
and high blood ketone levels are present during periods of starvation (Garber et al., 1974). 
Acetone is particularly enriched in gastric tissue due to the spontaneous decomposition of 
acetoacetate under acidic conditions, and some pathogens, including H. pylori, can utilize 
this excess acetone as a carbon source (Brahmachary et al., 2008). H. pylori is able to 
convert acetone to acetyl-CoA, the key biochemical necessary for carrying out the TCA 
cycle and generating energy. This biochemical pathway begins with the conversion of 
acetone to acetoacetate and is carried out by the enzyme acetone decarboxylase. H. pylori 
encodes a three gene operon, acxABC (HP0695-HP0697), that encodes acetone 
carboxylase (Corthésy-Theulaz et al., 1997). This operon is not essential for H. pylori 
survival, but deletion of the operon reduces the ability of H. pylori to colonize a mouse 
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model (Brahmachary et al., 2008). In this way, expression of acetone carboxylase may 
contribute to virulence.  
 The acxABC operon is transcribed using RNA polymerase in combination with 
the housekeeping factor, σ80 (Sharma et al., 2010). The operon contains an AT-rich 
region between the −35 and −10 sites, and possesses a Pribnow box at the −10 site 
(TATACT), which is characteristic of promoters in H. pylori (Forsyth & Cover, 1999). 
The acxABC operon is of particular interest because evidence exists that all three of H. 
pylori’s TCSTs as well as HP1021 regulate its expression (Pflock et al., 2007a; Wen et 
al., 2009; Loh et al., 2010; Markowsky et al., 2004 - unpublished). ArsR and the cloned 
DNA-binding domain of ArsR bind to the upstream regulatory region of acxA in vitro, 
and higher levels of acetone carboxylase are present when a null mutation in arsS is 
introduced in H. pylori strain J99 (Loh et al., 2010). In H. pylori strains G27 and 26695, 
acxABC transcription is repressed in pH conditions below 5.0. This suggests ArsR may 
be a repressor of acxABC under acidic conditions. Multiple ArsR DNA binding sites have 
been described within the promoter region of acxA, both upstream and downstream of the 
−35 hexamer (Quinlivan-Repasi et al., 2011 - unpublished). Unpublished macroarray 
data from our lab indicates that the CrdRS system also regulates acxABC. Null mutations 
in both crdR and crdS cause an increase in expression, indicating that CrdR may serve as 
a repressor (Markowsky et al., 2004 – unpublished). CrdR has been shown to interact 
directly with the upstream regulatory region using in vitro DNA binding studies 
(Quinlivan-Repasi et al., 2011 – unpublished). A microarray study identified acxABC as 
a member of the pH-independent regulon of FlgRS, where expression of all three genes 
of the operon was down-regulated in an flgS null mutant strain of 26695 (Wen et al., 
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2009). FlgR typically regulates genes under the control of a σ54 promoter (Brahmachary 
et al., 2004), therefore the σ80 promoter of the acxABC operon may preclude direct 
interaction between FlgR and the promoter of acxABC. The mechanism by which FlgS 
mediates regulation of acxABC is unknown, but FlgS may be able to phosphorylate other 
response regulators (Danielli et al., 2010). HP1021, the orphan response regulator, 
induces acxABC transcription and interacts physically with the upstream regulatory 
region of the operon. DNA-binding experiments produced four discrete complexes 
between HP1021 and acxA upstream DNA, indicating that HP1021 may bind multiple 
sites of the promoter (Pflock et al., 2007a). 
 Characterizing the multi-system regulation of acxABC has the potential to inform 
and improve therapeutic interventions in H. pylori infections. TCSTs have long been 
recognized as potential antibiotic targets in pathogenic bacteria due to their essential 
control over bacterial growth and virulence, however early attempts at developing drugs 
to interfere with signaling stalled due to poor selectivity (Gotoh et al., 2010). If acxABC 
is regulated by all H. pylori TCSTs, then it represents a nexus of regulation that is 
influenced by responses to multiple environmental stressors. The role of acxABC in H. 
pylori pathogenicity has not been fully explored, but the investment of multiple 
regulatory systems suggests that acetone metabolism may significantly affect the fitness 
of H. pylori in the dynamic environment of a human host. Understanding how TCSTs in 
H. pylori interact with each other, acxABC, and other critical regulon members will 
inform drug design by identifying key components of regulatory networks optimal for 
pharmacological intervention. 
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1.10 - Research Goals and Experimental Approach 
 The acetone carboxylase operon is an excellent model for studying TCST and 
regulatory overlap in H. pylori. Due to the fact that multiple regulatory systems impinge 
on the expression of the acetone carboxylase operon and the operon contributes to H. 
pylori’s ability to colonize an animal model, understanding the TCST-mediated 
mechanism of its regulation will provide insight into how H. pylori fine-tunes the 
regulation of genes important to survival. The research in this thesis focuses on further 
characterizing the physical interactions of ArsR and HP1021, a repressor and activator of 
acxABC, respectively, with the upstream regulatory region of this operon. The primary 
experimental techniques used to investigate the physical binding of response regulators to 
specific DNA sequences are electrophoretic mobility shift assays (EMSA). By localizing 
the binding sites of each response regulator relative to the promoter of acxABC, a better 
understanding of how each response regulator increases or decreases transcription as well 
as identification of the binding sequences recognized by each protein can be determined. 
Also, the networking or competition between DNA binding proteins can be assessed. 
Additionally, gene expression studies were conducted to ascertain inter-strain differences 
in the regulation of acxABC between H. pylori strains J99 and 26695. Comparing wild-
type H. pylori with strains containing null mutations in arsS, the expression of acxA in 
cells grown under neutral or acidic conditions was assayed via quantitative real-time PCR 
(qPCR). Understanding heterogeneity in TCST regulation of acxABC between strains of 
H. pylori will enhance our understanding of how strains differ in their ability to cause 
disease. 
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2 - Methods 
2.1 - Expression of ArsR and HP1021 
 Freezer stocks of M15 E. coli strains known to express 26695 ArsR and 26695 
HP1021 were obtained from Daniel Hallinger and Vanessa Quinlivan-Repasi, 
respectively (Quinlivan-Repasi et al., 2011 - unpublished). These strains are M15 E. 
coli/pQE30-26695arsR + pREP4 and M15 E. coli/pQE30-26695hp1021 + pREP4. These 
strains contained the open reading frame of each protein inserted within a pQE30 
expression vector (Qiagen). This expression vector system appends a 6X Histidine tag to 
the N terminus of each protein as an aid in purification. Each protein was expressed using 
a modified version of the native batch purification protocol from the QIAexpressionist 
manual. A freezer stock of each M15 E. coli strain containing pQE30 with the desired 
response regulator was inoculated into 10 mL of Luria-Bertani (LB) broth supplemented 
with 100 µg/mL ampicillin (Amp) and 50 µg/mL kanamycin (Kan). After overnight 
incubation at 37˚C, the entire culture was used to inoculate 250 mL of prewarmed LB 
Amp/Kan in a sterile baffled culture flask. The culture was then grown at 37˚C with 
shaking at 250 rpm until reaching an OD600 of 0.5-0.7. Prior to inducing expression, a 1 
mL sample, serving as an uninduced control, was taken from the culture, harvested via 
centrifugation, and resuspended in 25 µL of Laemmli Sample Buffer (BioRad). IPTG 
was added to the remaining culture to a final concentration of 1 mM to induce protein 
expression, and the culture was returned to the incubator. When expressing ArsR or 
HP1021, the culture was allowed to incubate for 4 hours or 2 hours, respectively. After 
incubation, another 1 mL sample was taken from the culture, pelleted, and resuspended in 
25 µL Laemmli Sample Buffer to serve as an induced control. The rest of the culture was 
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split into 50 mL aliquots and centrifuged at 4000 g for 20 minutes at 4˚C. Next, the 50 
mL cell pellets were resuspended in 4 mL NPI-10 lysis buffer (50mM NaH2PO4, 300mM 
NaCl, 10mM imidazole). Lysozyme (Fisher Scientific) was added to a final concentration 
of 1 mg/mL, and the samples were incubated for 30 minutes on ice with occasional 
mixing by inversion. The cells were lysed via sonication at maximum power on ice with 
six 10 second bursts with a 10 second pause in between each burst. Twelve units of 
Benzonase® nuclease (Novagen) was added per mL of lysate and incubated an additional 
15 minutes on ice. Each lysate was then centrifuged for 30 mins at 10,000 g at 4˚C to 
pellet cellular debris. The supernatant, containing the soluble fraction, was removed and 
stored at 4˚C while the pelleted insoluble fraction was resuspended to the original volume 
before centrifugation in NPI-10 lysis buffer and also stored at 4˚C. A 25 µL aliquot of 
both the soluble and insoluble fractions was mixed with 25 µL Laemmli Sample Buffer. 
In order to assess the solubility of the expressed protein, the uninduced control, induced 
control, soluble fraction, and insoluble fraction suspended in Laemmli Sample Buffer 
were boiled at 100˚C for 5 minutes and then run on SDS-PAGE gels stained with 
Coomassie Brilliant Blue. SDS-PAGE was conducted using 12% acrylamide 0.75 mm 
thick gels using the Mini-PROTEAN® III system (BioRad). After electrophoresis and 
staining, the expression level and solubility of the desired protein could be assessed. 
2.2 - Response Regulator Purification 
 Each protein was purified using the Ni-NTA gravity filtration system from 
Qiagen. Up to 12 mL of the soluble fraction of each protein was added to a 5 mL bed 
volume drip column containing 3 mL 50% Ni-NTA agarose slurry. Eluted fractions were 
run on SDS-PAGE gels to determine the fraction containing the purest response regulator 
	   18	  
protein, and the protein concentration was determined on a Nanodrop® 
spectrophotometer (Thermo). If the concentration was less than 2 mg/mL total protein, 
the protein was concentrated using 10kD Amicon Ultra-15 Centrifugal Units (Millipore). 
The protein was aliquoted in 80 µg increments and 10% glycerol was added by volume. 
The protein aliquots were stored at −20˚C for future experiments. 
2.3 - Electrophoretic Mobility Shift Assays 
2.3.1 - Probes 
 The DNA Probes for EMSAs detectable using the LightShift® Chemiluminescent 
EMSA Kit (Thermo) were biotin labeled. These probes (Table 2, Figure 2) were 
amplified via PCR from a plasmid template containing the entire upstream regulatory 
region of acxA (pCR-26695acxABC) obtained from Vanessa Quinlivan-Repasi 
(Quinlivan-Repasi et al., 2011 – unpublished). Later, some probes were amplified from 
existing probe stocks. All PCR reactions were conducted with Bullseye Taq® (Midsci) 
and biotinylated primers (Table 1). Unlabeled probes (Table 2) used in specific 
competition assays were also amplified via PCR using unbiotinylated primers (Table 1). 
The unrelated DNA used in nonspecific competition reactions was Epstein-Barr Nuclear 
Antigen DNA (EBNA) provided in the Lightshift® EMSA Optimization Kit (Thermo) 
(Table 1). 
 EMSA probes required further purification after PCR amplification. Biotinylated 
probes were run on native 6% acrylamide gels containing 4 µg/mL ethidium bromide. 
After electrophoresis, the probes were excised from the gel and purified using the “crush 
and soak method” (Sambrook & Russell, 2001). Gel samples were crushed using a small 
mortar within a microcentrifuge tube, mixed with 300 µL of acrylamide gel elution buffer 
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(300 mM NaOAc, 1mM EDTA pH 8.0), and shaken 24-72 hours at room temperature. 
Then the samples were centrifuged 10 minutes at 10,000 g to pellet the acrylamide gel 
fragments, and the supernatant containing the purified probes was collected and frozen at 
−20˚C. Unlabeled probes were purified using the Gel/PCR DNA Fragment Extraction Kit 
(IBI Scientific). 
Table 1. EMSA Probe Primers 
Name 5’ to 3’ sequence 
HP0694 Fwd.2 TCCCAGCCTAAGCACCATC 
HP0694 Fwd.2.btn Biotin-TCCCAGCCTAAGCACCATC 
AcxA-35Rev TTATTTCAAAGTTGTTTGT 
AcxA-35Rev.btn Biotin-TTATTTCAAAGTTGTTTGT 
Up.1 Rev AATAAAGTGAAAAGTAGTAA 
Up.2 Rev CCGATATTCATCTTAAATTA 
Up.3 Rev ATCATATAGGAAGAAAAATA 
Up.4 Rev AAGGCGAAATTCAATTCTAA 
Up.5 Fwd TTGATTTAATATCAGTTTAA 
Up.6 Fwd ATTTATATGATATTTTTGGG 
Up.7 Fwd TAGCGTTTTGAATAAATTTG 
Up.8 Fwd ACGCCAAATTTTCCCTTATT 
AcxA-35Fwd ATGATTTCCATTTAAAAATC 
AcxA-35Fwd.btn Biotin-ATGATTTCCATTTAAAAATC 
AcxARev2 CTTTACCAACTACGAAACT 
AcxARev.2.btn Biotin-CTTTACCAACTACGAAACT 
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Down.1 Rev TTGCCTTGAGCAACACTTTA 
Down.2 Rev AGACGCAAGAGTTCAGGTGA 
Down.3 Rev ACCATGACGGACACATTTTT 
Down.4 Fwd GCCACCGGCATCAATACCCA 
Down.5 Fwd TTCATTTAGACTCCTTGTAT 
Down.6 Fwd CCTATTAGAAGTATAAGGCT 
Table 2. EMSA Probes  
Probe 
Name 
Description Probe 
Size 
Primers Used to 
Amplify Probe 
Up Spans end of HP0694 translation to the 
−35 hexamer of H. pylori acxABC 
209 bp HP0694 Fwd.2 
AcxA-35Rev 
Up* Biotinylated Up HP0694 Fwd.2.btn 
AcxA-35Rev 
Up.1 Up probe truncated 39 bp from 3’ end 170 bp HP0694 Fwd.2 
Up.1 Rev 
Up.1* Biotinylated Up.1 HP0694 Fwd.2.btn 
Up.1 Rev 
Up.2 Up probe truncated 79 bp from 3’ end 130 bp HP0694 Fwd.2 
Up.2 Rev  
Up.2* Biotinylated Up.2 HP0694 Fwd.2.btn 
Up.2 Rev 
Up.3 Up probe truncated 119 bp from 3’ end 90 bp HP0694 Fwd.2 
Up.3 Rev 
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Up.3* Biotinylated Up.3 HP0694 Fwd.2.btn 
Up.3 Rev 
Up.4 Up probe truncated 159 bp from 3’ end 50 bp HP0694 Fwd.2 
Up.4 Rev 
Up.4* Biotinylated Up.4 HP0694 Fwd.2.btn 
Up.4 Rev 
Up.5 Up probe truncated 50 bp from 5’ end 159 bp Up.5 Fwd 
AcxA-35Rev 
Up.5* Biotinylated Up.5 Up.5 Fwd 
AcxA-35Rev.btn 
Up.6 Up probe truncated 90 bp from 5’ end 119 bp Up.6 Fwd 
AcxA-35Rev 
Up.6* Biotinylated Up.6 Up.6 Fwd 
AcxA-35Rev.btn 
Up.7 Up probe truncated 130 bp from 5’ end 79 bp Up.7 Fwd 
AcxA-35Rev 
Up.7* Biotinylated Up.7 Up.7 Fwd 
AcxA-35Rev.btn 
Up.8 Up probe truncated 170 bp from 5’ end 39 bp Up.8 Fwd 
AcxA-35Rev 
Up.8* Biotinylated Up.8 Up.8 Fwd 
AcxA-35Rev.btn 
Down Starts at −35 hexamer of H. pylori acxABC 
and ends downstream of the start of 
translation 
175 bp AcxA-35Fwd 
AcxARev2 
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Down* Biotinylated Down AcxA-35Fwd.btn 
AcxARev2 
Down.1 Down probe truncated 40 bp from 5’ end 135 bp Down.1 Fwd 
AcxARev2 
Down.1* Biotinylated Down.1 Down.1 Fwd 
AcxARev2.btn 
Down.2 Down probe truncated 80 bp from 5’ end 95 bp Down.2 Fwd 
AcxARev2 
Down.2* Biotinylated Down.2 Down.2 Fwd 
AcxARev2.btn 
Down.3 Down probe truncated 120 bp from 5’ end 55 bp Down.3 Fwd 
AcxARev2 
Down.3* Biotinylated Down.3 Down.3 Fwd 
AcxARev2.btn 
Down.4 Down probe truncated 55 bp from 3’ end 120 bp AcxA-35Fwd 
Down.4 Rev 
Down.4* Biotinylated Down.4 AcxA-35Fwd.btn 
Down.4 Rev 
Down.5 Down probe truncated 95 bp from 3’ end 80 bp AcxA-35Fwd 
Down.5 Rev 
Down.5* Biotinylated Down.5 AcxA-35Fwd.btn 
Down.5 Rev 
Down.6 Down probe truncated 135 bp from 3’ end 40 bp AcxA-35Fwd 
Down.6 Rev 
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Figure 2. Sizes and locations of acxA EMSA probes. 
(A) This schematic shows the location of the Up probe and all of its truncations relative 
to the −38 nucleotide in the upstream regulatory region of acxA. (B) This schematic 
shows the location of the Down probe and all of its truncations relative to the −37 
nucleotide of the acxA promoter. The blue arrow indicates the transcriptional start site of 
acxA while the coding region of acxA is within the labeled rectangle. 
 
 
 
Down.6* Biotinylated Down.6 AcxA-35Fwd.btn 
Down.6 Rev 
EBNA Unlabeled Epstein-Barr nuclear antigen 
DNA with the binding site 5’-
…TAGCATATGCTA…-3’) 
25 bp  
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2.3.2 - Binding Reactions 
 The EMSA protocol used in this study was adapted from the LightShift® EMSA 
Optimization Kit Protocol (Thermo) and ArsR EMSAs performed by Loh et al. (Loh et 
al., 2010). Generally, four binding reactions were conducted for each biotinylated probe: 
1. Biotinylated Probe  
2. Biotinylated Probe + Response Regulator 
3. Biotinylated Probe + Response Regulator + 500x Unlabeled Probe 
4. Biotinylated Probe + Response Regulator + 500x Unlabeled nonspecific DNA 
 The amount of biotinylated probe, unlabeled probe, and protein was varied between 
experiments in an effort to empirically determine binding conditions and specificity, but 
within the binding reactions of an individual experiment the amounts were kept constant. 
 The total volume of each binding reaction was 30 µL. Reagents were combined in 
the following order: 6 µL 5x binding buffer, 2 µL poly dI-dC (1 mg/mL), unlabeled 
probe (if necessary), 3-6 µg protein (if necessary), and ddH2O to 29 µL. The binding 
reaction was then incubated for 10 minutes at room temperature. Lastly, 1 µL (0.5-2 ng) 
labeled probe was added to each binding reaction and incubated for an additional 20 
minutes at room temperature.  
 The binding buffers used in the EMSAs were obtained from previous studies. The 
ArsR 5x binding buffer contained 50 mM Tris-HCl, 250 mM KCl, 5 mM DTT, 12.5% 
glycerol, 25 mM MgCl2, and 0.25% NP-40 (Loh et al., 2010). The HP1021 5x binding 
buffer contained 50 mM Tris-HCL, 50 mM KCl, 5 mM DTT, 5% glycerol, and 25 mM 
EDTA (Pflock et al., 2007a). 
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2.3.3 - Electrophoresis 
 Binding reactions were electrophoresed immediately after incubation with the 
biotinylated probe. First, 7.5 µL loading buffer (Thermo) was added to each binding 
reaction, then 20 µL of each reaction was loaded onto a 6% acrylamide native PAGE gel. 
Gels were electrophoresed for at least 30 minutes, 100V prior to loading samples. The 
binding reactions along with 3 µL of 2-log biotinylated DNA ladder (New England 
Biolabs) were electrophoresed in 0.5x TBE at 100 V until the unbound biotinylated 
probes were approximately 1 cm from the bottom of the gel. Total run time depended on 
the specific biotinylated probe being used. 
2.3.4 - Membrane Blotting and Detection 
 Native PAGE gels were blotted to Zeta-Probe GT® nylon membranes (BioRad) 
immediately after electrophoresis. Blotting was conducted according to the 
manufacturer’s protocol using the BioRad Mini Trans-Blot® cell. Fiber pads, filter paper, 
and nylon membranes were soaked in cold 0.5x TBE for 10 minutes before blotting. 
Blotting transfer was conducted in cold 0.5x TBE for 30 minutes at 380 mA. After 
blotting, the nylon membranes were crosslinked in a GS Gene Linker® (BioRad) at 125 
µJoules for 3 minutes and stored dry at 4˚C until the detection protocol could be 
completed. 
 The detection procedure was carried out using the LightShift® EMSA kit protocol. 
After detection, the blots were exposed to CL-XPosure® X-ray film (Thermo) for 30s 
and processed in a Konica film processor. Additional exposures of shorter or longer 
intervals were conducted if necessary including “burnout” exposures where the X-ray 
film was exposed until luminescence ceased. 
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2.4 - Helicobacter pylori Liquid Culture and Acid Shock 
 Freezer stocks of Helicobacter pylori strains (Table 3) were inoculated on TSA 
plates supplemented with 5% Sheep’s Blood and incubated 24-48 hours at 37˚C in a 5% 
CO2 atmosphere. Each strain was then passed to a fresh agar plate 24 hours before liquid 
inoculation. One full plate of cells was swabbed into 1 mL of sterile Sulfite Free Brucella 
Broth (SFBB) with 10% fetal calf serum and 20 µg/mL vancomycin at pH 7. The OD600 
of this suspension was recorded and used to inoculate 25 mL of sterile SFBB in a baffled 
vented 125 mL culture flask to an OD600 of 0.1. Culture flasks were then incubated at 
37˚C in a 5% CO2 atmosphere in a rotating incubator. The cultures were allowed to grow 
until the cells reached an OD600 of 0.8 − 1.0. At this point, the cultures were split into two 
12.5 mL aliquots and centrifuged at 4000 rpm for 5 minutes. The supernatant was 
discarded, and one pellet serving as a control was resuspended in 12.5 mL sterile SFBB 
pH 7 while the other pellet undergoing the acid shock was resuspended in 12.5 mL sterile 
SFBB pH 5. Each culture was then incubated at 37˚C in a 5% CO2 atmosphere in a 
rotating incubator for 1 hour. After the incubation, the cultures were removed to room 
temperature and the OD600 of each was determined. Using a standard conversion factor of 
1 OD600 unit = 5x108 cells/mL, an aliquot containing 1x109 cells was transferred from 
each culture flask to a microcentrifuge tube. These aliquots were pelleted at 4000 g for 5 
minutes, the supernatant was discarded, and the pellets were frozen at −80˚C. 
2.5 - RNA Extraction 
 Total RNA was extracted from each cell pellet according to the manufacturer’s 
protocol using the MagMAX™-96 for Microarrays Total RNA Isolation Kit (Life 
Technologies) and the AM1839 Spin Program on a MagMAX™ Express Magnetic 
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Particle Processor (Life Technologies). Purified RNA concentrations were analyzed on a 
Nanodrop® spectrophotometer (Thermo) and frozen at −80˚C. 
Table 3. Helicobacter pylori Strains 
Name  Purpose Source 
26695 WT Fully-sequenced cag PAI+ 
laboratory strain 
Mark Forsyth 
College of William & 
Mary 
26695/arsS::cat 26695 with arsS null mutation 
J99 WT Fully-sequenced cag PAI+ 
laboratory strain 
J99/arsS::km J99 with arsS null mutation 
2.6 - Quantitative Real Time PCR 
 Quantitative real time PCR (qPCR) using the −2∆∆Ct method was carried out to 
determine the expression levels of acxA relative to housekeeping gene glk encoding 
glucokinase (HP1103) in all H. pylori strains grown at pH 7 or pH 5. The primers used 
for acxA were acxA.2 Fwd (5’-TGCAATAAGGGTTTTGAGCA-3’) and acxA.2 Rev 
(5’-GATAACCACTTGCCCCTTGA-3’) amplifying a product of 177-bp. The primers 
used for glk were glk Fwd (5’-GGCTTGGGGTAAGCACTCTT-3’) and glk Rev (5’-
ACCTTTCCGCGCTCACAT-3’) amplifying a product of 156-bp. The qPCR was 
performed using the Power SYBR® Green RNA-to-Ct™ 1-Step Kit (Life Technologies) 
on a StepOne™ Real Time PCR System (Applied Biosystems) according to 
manufacturer’s protocols. PCR conditions were run according to manufacturer’s 
protocols with an annealing temperature of 58˚C. Reactions were 20 µL with 1-2 ng of 
total RNA serving as a template and were performed in triplicate. Data was processed 
using DataAssist™ software (Applied Biosystems). 
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3 - Results and Discussion 
3.1 - Localizing ArsR Binding Sites via Electrophoretic Mobility Shift Assays 
 All DNA probes used for electrophoretic mobility shift assays (EMSAs) were 
amplified from the upstream regulatory region of acxA from H. pylori strain 26695 
(Table 2, Figure 2). The cloned and expressed ArsR used in this study was also from 
strain 26695. The strategy used to localize the ArsR binding sites involved interrogating 
ArsR with successively truncated DNA probes from both the 5’ and 3’ ends of the DNA. 
In this way, one can infer the presence of a binding site by looking for the loss of a shift 
between successive truncations (Figures 3 through 6). The binding sites were localized to 
approximately 40 base pair regions of the acxA promoter, although the actual sequence 
ArsR binds to may be smaller (Table 4). The data from Figures 3 through 6 suggests that 
ArsR binds upstream of the acxA −35 hexamer as well as 139 nucleotides downstream of 
the acxA transcriptional start site. Examination of protein expression in H. pylori suggests 
ArsR is a repressor of acxA transcription, therefore a binding site within the coding 
sequence of acxA may function to interfere with successful transcription of the gene (Loh 
et al., 2010). Quantitative real time PCR data shown in the current study corroborates the 
classification of ArsR functioning as a repressor (see below). 
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Figure 3. ArsR EMSA with Up.1* - Up.4* probes. This figure illustrates ArsR 
interrogated with DNA probes amplified from the upstream regulatory region of acxA. In 
this case, the probes are amplified from the region upstream of the −38 nucleotide before 
the start of acxA transcription but downstream of the neighboring gene, hp0694. The 
schematic shows the length of each biotinylated probe. Each EMSA is shown below the 
particular biotinylated probe used in the experiment. Lanes labeled L contain a 2-log 
biotinylated DNA ladder (New England Biolabs). Reactions A1-D1 contain 1 ng Up.1*. 
Reactions A2-D2 contain 1 ng Up.2*. Reactions A3-D3 contain 1 ng Up.3*. Reactions 
A4-D4 contain 1 ng Up.4*. All A reactions contain only the biotinylated probe. All B 
reactions contain biotinylated probe and 5 µg ArsR. All C reactions contain biotinylated 
probe, 5 µg ArsR, and 100x concentration of unbiotinylated probe as a specific 
competitor. Reaction D1 contains biotinylated probe, 5 µg ArsR, and 52x EBNA as a 
nonspecific competitor. Reaction D2 contains biotinylated probe, 5 µg ArsR, and 40x 
EBNA. Reaction D3 contains biotinylated probe, 5 µg ArsR, and 28x EBNA. Reaction 
D4 contains biotinylated probe, 5 µg ArsR, and 15x EBNA. The yellow arrows indicate 
the loss of an ArsR-probe complex between Up.3* and Up.4*, and a yellow rectangle 
labeled “ArsR BS 1” indicates the suspected binding site of ArsR between nucleotides 
−196 and −156. 
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Figure 4. ArsR EMSA with Up.5* - Up.8* probes. This figure illustrates ArsR 
interrogated with DNA probes amplified from the upstream regulatory region of acxA. In 
this case, the probes are amplified from the region upstream of the −38 nucleotide before 
the start of acxA transcription but downstream of the neighboring gene, hp0694. The 
schematic shows the length of each biotinylated probe. Each EMSA is shown below the 
particular biotinylated probe used in the experiment. Lanes labeled L contain a 2-log 
biotinylated DNA ladder (New England Biolabs). Reactions A1-D1 contain 0.5 ng 
Up.5*. Reactions A2-D2 contain 0.5 ng Up.6*. Reactions A3-D3 contain 0.5 ng Up.7*. 
Reactions A4-D4 contain 0.5 ng Up.8*. All A reactions contain only the biotinylated 
probe. All B reactions contain biotinylated probe and 5 µg ArsR. All C reactions contain 
biotinylated probe, 5 µg ArsR, and 500x concentration of unbiotinylated probe as a 
specific competitor. All D reactions contain biotinylated probe, 5 µg ArsR, and 500x 
EBNA as a nonspecific competitor. The yellow arrows indicate the loss of an ArsR-probe 
complex between Up.5* and Up.6*, and a yellow rectangle labeled “ArsR BS 1” 
indicates the suspected binding site of ArsR between nucleotides −196 and −156. 
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Figure 5. ArsR EMSA with Down.1* - Down.3* probes. This figure illustrates ArsR 
interrogated with DNA probes amplified from the upstream regulatory region of acxA. In 
this case, the probes are amplified from the region downstream of the −37 nucleotide into 
the open reading frame of acxA. The schematic shows the length of each biotinylated 
probe. Each EMSA is shown below the particular biotinylated probe used in the 
experiment. Lanes labeled L contain a 2-log biotinylated DNA ladder (New England 
Biolabs). Reactions A1-D1 contain 1 ng Down.1*. Reactions A2-D2 contain 1 ng 
Down.2*. Reactions A3-D3 contain 1 ng Down.3*. All A reactions contain only the 
biotinylated probe. All B reactions contain biotinylated probe and 5 µg ArsR. All C 
reactions contain biotinylated probe, 5 µg ArsR, and 100x concentration of 
unbiotinylated probe as a specific competitor. Reaction D1 contains biotinylated probe, 5 
µg ArsR, and 42x EBNA as a nonspecific competitor. Reaction D2 contains biotinylated 
probe, 5 µg ArsR, and 29x EBNA. Reaction D3 contains biotinylated probe, 5 µg ArsR, 
and 17x EBNA. The purple arrow indicates the presence of an ArsR-probe complex 
persisting to the smallest probe, and a purple rectangle labeled “ArsR BS 2” indicates the 
suspected binding site of ArsR between nucleotides +84 and +139.  
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Figure 6. ArsR EMSA with Down.4* - Down.6* probes. This figure illustrates ArsR 
interrogated with DNA probes amplified from the upstream regulatory region of acxA. In 
this case, the probes are amplified from the region downstream of the −37 nucleotide into 
the open reading frame of acxA. (A) The schematic shows the length of each biotinylated 
probe. Each EMSA is shown below the particular biotinylated probe used in the 
experiment. Lanes labeled L contain a 2-log biotinylated DNA ladder (New England 
Biolabs). Reactions A1-D1 contain 0.5 ng Down.4*. Reactions A2-D2 contain 0.5 ng 
Down.5*. Reactions A3-D3 contain 0.5 ng Down.6*. All A reactions contain only the 
biotinylated probe. All B reactions contain biotinylated probe and 5 µg ArsR. All C 
reactions contain biotinylated probe, 5 µg ArsR, and 500x concentration of 
unbiotinylated probe as a specific competitor. All D reactions contain biotinylated probe, 
5 µg ArsR, and 500x EBNA as a nonspecific competitor. None of the probes bound ArsR 
in these EMSAs. A purple rectangle labeled “ArsR BS 2” indicates the suspected binding 
site of ArsR between nucleotides +84 and +139. (B) This EMSA shows ArsR binding to 
the Down* probe. All lanes contain 1 ng of Down*.  
 
3.2 - Localizing HP1021 Binding Sites via Electrophoretic Mobility Shift Assays 
 The same strategy used to localize ArsR binding sites was employed to localize 
binding of HP1021 to EMSA probes (Figures 7 through 10). The data displayed in 
Figures 7 through 10 suggest the presence of three HP1021 binding sites upstream of the 
−35 hexamer of the acxA promoter and three binding sites downstream of this hexamer 
(Table 4). The EMSAs performed with HP1021 were different than those performed with 
ArsR in that multiple HP1021-probe complexes were visible within a single gel. Multiple 
shifted complexes of differing molecular weight indicate the potential presence of 
multiple HP1021 binding sites on the same probe. We hypothesize that the lower 
molecular weight complexes occur when HP1021 is bound to fewer binding sites and 
higher molecular weight complexes occur when more sites on the probe are bound to 
HP1021. In Figure 7, the first HP1021 binding site is predicted to lie between nucleotides 
−196 and −156 relative to the +1 transcriptional start site of acxA whereas Figure 8 
indicates that the first binding site lies between nucleotides −156 and −116. The reason 
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for this discrepancy is unclear and could be resolved by interrogating HP1021 with 
distinct 40 bp probes from nucleotides −196 to −156 or −156 to −116. HP1021 binding 
sites 2/3 are located within the same 40 bp sequence identified using this strategy. The 
same is true of HP1021 binding sites 5/6. A previous transcriptional profiling study of H. 
pylori strain 26695 identified HP1021 as an activator of acxA transcription and also 
confirmed the binding of HP1021 to a 210 bp DNA probe encompassing the promoter of 
acxA (Pflock et al., 2007a). That study also demonstrated the presence of four distinct 
HP1021-probe complexes in gel retardation experiments with this probe, similar to the 
multiple complexes detected in the current study (Figures 7 through 9). The identification 
of HP1021 binding sites upstream of the −35 hexamer in the acxA promoter are 
consistent with the hypothesis that HP1021 enhances transcription of the acxABC operon, 
however the presence of binding sites within the open reading frame of acxA would be 
more typical of transcriptional repressor sites. EMSAs such as these provide information 
on the binding ability of transcription factors to specific DNA probes but do not elucidate 
the complex binding dynamics of response regulators within a living cell. 
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Figure 7. HP1021 EMSA with Up.1* - Up.4* probes. This figure illustrates HP1021 
interrogated with DNA probes amplified from the upstream regulatory region of acxA. In 
this case, the probes are amplified from the region upstream of the −38 nucleotide before 
the start of acxA transcription but downstream of the neighboring gene, hp0694. The 
schematic shows the length of each biotinylated probe. Each EMSA is shown below the 
particular biotinylated probe used in the experiment. Lanes labeled L contain a 2-log 
biotinylated DNA ladder (New England Biolabs). Reactions A1-D1 contain 0.5 ng 
Up.1*. Reactions A2-D2 contain 0.5 ng Up.2*. Reactions A3-D3 contain 0.5 ng Up.3*. 
Reactions A4-D4 contain 0.5 ng Up.4*. All A reactions contain only the biotinylated 
probe. All B reactions contain biotinylated probe and 5 µg HP1021. All C reactions 
contain biotinylated probe, 5 µg HP1021, and 500x concentration of unbiotinylated probe 
as a specific competitor. All D reactions contain biotinylated probe, 5 µg HP1021, and 
500x EBNA as a nonspecific competitor. The black arrows indicate the loss of the two 
highest molecular weight HP1021-probe complexes between Up.1* and Up.2*, and the 
red arrow indicates the loss of the lowest molecular weight HP1021-probe complex 
between Up.3* and Up.4*. The red rectangle labeled “HP1021 BS 1” indicates a binding 
site of HP1021 between nucleotides −196 and −156. The black rectangle labeled 
“HP1021 BS 2/3” indicates the two suspected binding sites of HP1021 between 
nucleotides −116 and −76. 
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Figure 8. HP1021 EMSA with Up.5* - Up.8* probes. This figure illustrates HP1021 
interrogated with DNA probes amplified from the upstream regulatory region of acxA. In 
this case, the probes are amplified from the region upstream of the −38 nucleotide before 
the start of acxA transcription but downstream of the neighboring gene, hp0694. The 
schematic shows the length of each biotinylated probe. Each EMSA is shown below the 
particular biotinylated probe used in the experiment. Lanes labeled L contain a 2-log 
biotinylated DNA ladder (New England Biolabs). Reactions A1-D1 contain 0.5 ng 
Up.5*. Reactions A2-D2 contain 0.5 ng Up.6*. Reactions A3-D3 contain 0.5 ng Up.7*. 
Reactions A4-D4 contain 0.5 ng Up.8*. All A reactions contain only the biotinylated 
probe. All B reactions contain biotinylated probe and 5 µg HP1021. All C reactions 
contain biotinylated probe, 5 µg HP1021, and 500x concentration of unbiotinylated probe 
as a specific competitor. All D reactions contain biotinylated probe, 5 µg HP1021, and 
500x EBNA as a nonspecific competitor. The red arrow indicates the loss of the highest 
molecular weight HP1021-probe complex between Up.6* and Up.7*. The black arrows 
indicate the loss of two HP1021-probe complexes between Up.7 and Up.8*. The red 
rectangle labeled “HP1021 BS 1” indicates a suspected binding site between nucleotides 
−156 and −116. The black rectangle labeled “HP1021 BS 2/3” indicates two suspected 
binding sites of HP1021 between nucleotides −116 and -76. 
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Figure 9. HP1021 EMSA with Down.1* - Down.3* probes. This figure illustrates 
HP1021 interrogated with DNA probes amplified from the upstream regulatory region of 
acxA. In this case, the probes are amplified from the region downstream of the −37 
nucleotide into the open reading frame of acxA. The schematic shows the length of each 
biotinylated probe. Each EMSA is shown below the particular biotinylated probe used in 
the experiment. Lanes labeled L contain a 2-log biotinylated DNA ladder (New England 
Biolabs). Reactions A1-D1 contain 0.5 ng Down.1*. Reactions A2-D2 contain 0.5 ng 
Down.2*. Reactions A3-D3 contain 0.5 ng Down.3*. All A reactions contain only the 
biotinylated probe. All B reactions contain biotinylated probe and 5 µg HP1021. All C 
reactions contain biotinylated probe, 5 µg HP1021, and 500x concentration of 
unbiotinylated probe as a specific competitor. All D reactions contain biotinylated probe, 
5 µg HP1021, and 500x EBNA as a nonspecific competitor. The green arrows indicate 
the loss of an HP1021-probe complex between Down.1* and Down.2*. The orange 
arrows indicate the persistence of two HP1021-probe complexes until the smallest probe. 
A green rectangle labeled “HP1021 BS 4” indicates the suspected binding site of HP1021 
between nucleotides +4 and +44. The orange rectangle labeled “HP1021 BS 5/6” 
indicates the presence of two binding sites of HP1021 between nucleotides +84 and 
+139.  
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Figure 10: HP1021 EMSA with Down.4* - Down.6* probes. This figure illustrates 
HP1021 interrogated with DNA probes amplified from the upstream regulatory region of 
acxA. In this case, the probes are amplified from the region downstream of the −37 
nucleotide into the open reading frame of acxA. (A) The schematic shows the length of 
each biotinylated probe. Each EMSA is shown below the particular biotinylated probe 
used in the experiment. Lanes labeled L contain a 2-log biotinylated DNA ladder (New 
England Biolabs). Reactions A1-D1 contain 0.5 ng Down.4*. Reactions A2-D2 contain 
0.5 ng Down.5*. Reactions A3-D3 contain 0.5 ng Down.6*. All A reactions contain only 
the biotinylated probe. All B reactions contain biotinylated probe and 5 µg HP1021. All 
C reactions contain biotinylated probe, 5 µg HP1021, and 500x concentration of 
unbiotinylated probe as a specific competitor. All D reactions contain biotinylated probe, 
5 µg HP1021, and 500x EBNA as a nonspecific competitor. The green arrows indicate 
the loss of an HP1021-probe complex between Down.5* and Down.6*. A green rectangle 
labeled “HP1021 BS 4” indicates the suspected binding site of HP1021 between 
nucleotides +4 and +44. The orange rectangle labeled “HP1021 BS 5/6” indicates the 
presence of two binding sites of HP1021 between nucleotides +84 and +139. (B) This 
EMSA shows HP1021 binding to the Down* probe. All lanes contain 1 ng of Down*.   
 
Table 4. Response Regulator Binding 
Sites  
Binding Site Designation Sequence 
ArsR Binding Site 1 
TTGATTTAATATCAGTTTAATATTTTT
CTTCCTATATGAT 
ArsR Binding Site 2 
ACCATGACGGACACATTTTTTGTGAA
AGAAAATGGCAGTTTCGTAGTTGGTA
AAG 
HP1021 Binding Site 1 (predicted based on 
results shown in Figure 7) 
TTGATTTAATATCAGTTTAATATTTTT
CTTCCTATATGAT 
HP 1021 Binding Site 1 (predicted based on 
results shown in Figure 8) 
ATTTATATGATATTTTTGGGTAATTT
AAGATGAATATCGG 
HP 1021 Binding Sites 2 and 3 
TAGCGTTTTGAATAAATTTGTTACTA
CTTTTCACTTTATT 
HP1021 Binding Site 4 
TTGCCTTGAGCAACACTTTAATACAA
GGAGTCTAAATGAA 
HP 1021 Binding Sites 5 and 6 
ACCATGACGGACACATTTTTTGTGAA
AGAAAATGGCAGTTTCGTAGTTGGTA
AAG 
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3.3 - Binding Specificity and Competition Assays 
 In EMSA protocols, competition reactions are performed in order to examine 
binding specificity between the response regulator and the target sequence of the probe. 
Unlabeled probes identical in sequence to the labeled probe are added to test for specific 
competition. Another reaction containing unrelated DNA serves as a nonspecific 
competitor. The amount of nonspecific competitor should at least equal the fold 
concentration of the specific competitor, however for several EMSAs (Figures 3, 5, 6B, 
10B), review of experimental records indicated an error where significantly less 
nonspecific competitor was added than previously thought. For these EMSAs, the fold 
concentration of nonspecific competitor Epstein-Barr Nuclear Antigen DNA (EBNA) is 
far below the fold concentration of the specific competitor, therefore the nonspecific 
reactions need to be repeated with an appropriate concentration of EBNA to ensure it 
does not interfere with specific binding between protein and probe. Specific competition 
is essential for confirming that the interaction between response regulator and probe is 
sequence specific, however in many of the EMSAs in this study, specific competition 
was difficult to demonstrate. In Figure 11, the ability of increasing concentrations of 
unlabeled Up probe to compete away ArsR binding to Up* was assayed. After 600x Up 
was added, an appreciable loss of shifting was observed, although even after the addition 
of 800x Up probe some shifting remained. The inability to completely compete away 
binding even with a large excess of specific competitor demonstrates a high avidity 
between ArsR and its binding sequences. The addition of up to 1032x of the nonspecific 
competitor EBNA did not compete away binding. In all other EMSAs, approximately 
100x − 500x specific competitor was added, therefore there may not have been enough 
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unlabeled probe to demonstrate competition. In the case of Figure 9 where multiple 
HP1021-probe complexes were observed, specific competition was only able to compete 
away the formation of the lowest molecular weight protein-probe complex. This 
information may provide some insight into the binding affinity of HP1021 to its various 
binding sites, with sites of lowest affinity being more easily competed away than others. 
 It is uncertain why specific competition was so difficult to demonstrate compared to 
similar experiments performed in other studies. In a study by Loh et al., specific 
competition was demonstrated between the DNA binding domain of ArsR and labeled 
probes from the promoter regions of acxA with a 20x excess of unlabeled probe (Loh et 
al., 2010). Pflock et al. were able to significantly compete away binding between 
HP1021 and the promoter of acxA with a 50x excess of unlabeled probe (Pflock et al., 
2007a). When binding reactions for specific competition are prepared, the protein of 
interest and the unlabeled probe serving as the specific competitor are co-incubated 
before the labeled probe is added. The protein should have the same affinity for the 
labeled probe and the unlabeled probe, therefore specific competition should occur most 
readily when the molar concentration of protein is lower than the molar concentration of 
specific competitor. However, in Loh’s study, competition was observed even when 1000 
times more ArsR was present than total probe. If all of the ArsR was capable of binding 
DNA, then all of the probe, both labeled and unlabeled, should have shifted. One possible 
explanation for this discrepancy could be that not all of the ArsR used in this study, nor 
all of the ArsR DNA binding domain used in Loh’s study, was in a state capable of 
binding its target sequence. In the case of the EMSAs presented in this study, only a 
portion of the protein in each reaction may have been able to bind DNA. This behavior 
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could be an artifact of the experimental binding conditions present in EMSAs or due to 
the presence of inactive/unphosphorylated ArsR. 
 
 
 
Figure 11. ArsR EMSA with Up* and Up Competition Assays. This figure illustrates 
ArsR binding to the Up* probe and the effect of increasing concentrations of specific 
competitor Up probe on shifting. Lanes marked L contain a 2-log biotinylated DNA 
ladder (New England Biolabs). All EMSA reactions contained 1 ng of Up* labeled 
probes. Successive loss of shifting was observed with increasing concentrations of Up 
probe, however no effect on shifting was observed upon addition of the nonspecific 
competitor EBNA. 
 
3.4 - Modeling Regulation of acxA with ArsR and HP1021 
 Figures 12 and 13 present hypothetical models of the ArsR and HP1021 binding 
landscapes near acxABC and the mechanism by which each protein alters acxABC 
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transcription. These models are based on EMSA data from this study and data from 
previous studies detailing the impact of each response regulator on acxA transcription 
(Pflock et al., 2007a; Loh et al., 2010). It should be noted that the binding order predicted 
by these figures is speculative but could be confirmed experimentally by examining the 
binding affinity of each response regulator for a specific binding site. In Figure 12, at low 
concentrations of active ArsR only the high affinity binding site upstream of the −35 
hexamer is bound, having little effect on acxA transcription. As concentrations of active 
ArsR increase, perhaps by increased phosphorylation by the cognate histidine kinase 
ArsS, ArsR binds to the lower affinity binding site within the coding sequence of acxA, 
repressing transcription. Other mechanisms such as interactions between ArsR facilitating 
DNA looping could stabilize repression of acxA.  
 Figure 13 details a possible mechanism for HP1021-mediated induction of acxA 
expression. At low concentrations of active HP1021, few high affinity sites would be 
bound, resulting in little effect on acxA expression. As the concentration of active 
HP1021 increases, more of the binding sites upstream of the −35 hexamer would be 
bound, possibly increasing the strength of the acxA promoter and increasing transcription. 
If the HP1021 binding sites located in the coding region of acxA are only bound when 
HP1021 concentrations are very high, these sites could represent a negative regulatory 
mechanism to prevent overexpression of acxA when HP1021 concentrations exceed a 
certain threshold. This could be an adaptive mechanism to prevent unnecessarily high 
expression levels of acxA. 
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Figure 12. Hypothetical model for the transcriptional regulation of acxA by ArsR. 
ArsR binding sites are labeled in green. As the concentration of active, phosphorylated 
ArsR~P increases in the cell, high affinity sites would be bound first followed by low 
affinity sites, increasingly repressing acxA transcription. Possible protein-protein 
interactions between active ArsR~P could stabilize the repression of acxA. 
 
 
Figure 13: Hypothetical model for the transcriptional regulation of acxA by 
HP1021. HP1021 binding sites are labeled in blue. When HP1021 concentration is low, 
few sites are bound and acxA concentration remains limited. As concentrations of 
HP1021 increase, high affinity sites in the promoter could enhance the transcription of 
acxA. Once HP1021 concentrations exceed a threshold, low affinity sites within the acxA 
coding region would be bound, serving as a negative regulatory mechanism to limit 
overexpression of acxA. 
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3.5 - Overlapping Binding Sites of ArsR and HP1021 
 The complex binding patterns of ArsR and HP1021 to the upstream regulatory 
regions of acxA as well as within the coding region of acxA suggest an intricate 
mechanism of regulation. All ArsR binding sites identified in this study overlap with 
putative HP1021 binding sites. The DNA probe truncation technique used to localize 
binding sites was limited in resolution to 40 base pairs, so the actual binding sites of 
ArsR and HP1021 may not physically overlap, but they appear to be close together. 
Combined with evidence from the literature that ArsR functions as a repressor of 
transcription and HP1021 functions as an activator, these two proteins may compete for 
binding sites in order to effect differential regulation of acxA. ArsR has been shown to 
bind the promoter of acxA most strongly when phosphorylated, but the factors that 
influence HP1021 binding are unknown (Pflock et al., 2007a; Loh et al., 2010).  
3.6 - Inter-strain Variation in acxA Expression  
 Quantitative real-time PCR (qPCR) was conducted on H. pylori strains listed in 
Table 3 assaying for acxA expression (Figures 14 and 15). Grown under either neutral or 
acidic conditions, relatively modest repression of acxA was observed in the H. pylori 
26695 arsS null mutant compared to wild-type. This is not consistent with observations 
that ArsR functions as a repressor of acxA, however the repression observed was less 
than two-fold that of the wild-type which may not be biologically significant. In the H. 
pylori J99 strains, derepression of acxA was observed in the arsS null mutant at 4.4-fold 
and 2.6-fold when grown at pH 7 and pH 5, respectively. Thus derepression of acxA in 
the J99 arsS null mutant is consistent with a global analysis of protein expression (Loh et 
al., 2010). These qPCR data provide direct evidence that ArsRS-dependent regulation of 
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acxA occurs on the level of transcription, clarifying the Loh et al. study that only 
analyzed protein levels of AcxA, AcxB, and AcxC. Loh et al. did not investigate H. 
pylori strain 26695. Inter-strain variation in ArsRS regulation of acxA is exhibited by H. 
pylori strains 26695 and J99, exemplifying the difficulty in comparing studies conducted 
on different H. pylori strains. Differences in bacterial strains have confounded H. pylori 
TCST research in the past. As an example, the CrdRS TCST system was determined to 
be required for acid resistance in strain J99 but not in strains 26695 and G27 (Loh & 
Cover, 2006; Pflock et al., 2007b). Variability in TCST regulation between H. pylori 
strains has a profound impact on virulence, and understanding the mechanism by which 
different strains modulate the expression of virulence genes can impact clinical strategies 
in treating H. pylori infections.  
3.7 – Future Considerations 
 One of the primary weaknesses of the EMSA data presented in this study is the 
inconsistent ability to specifically compete away shifting. Concentrations of 100x – 500x 
unlabeled DNA probes relative to labeled probes failed to demonstrate specific 
competition in many cases. Only shifts observed with Down.2* and Down.3* binding to 
ArsR (Figure 5) and the lowest molecular weight shift with Down.1* - Down.3* binding 
to HP1021 (Figure 9) were clearly competed away in the specific competition reaction. 
This data suggests that most of the binding sites observed are of such high affinity to each 
response regulator that they cannot reasonably be competed away using the current 
reaction conditions. Reducing the molarity of the protein in each reaction so that it is less 
than the molarity of the unlabeled probe should theoretically ensure near complete 
specific competition if all protein binds the unlabeled probe, however attempts to reduce 
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the amount of protein in each reaction to 3 µg or below failed to reproducibly produce 
shifts (data not shown). Another strategy to improve competition outcomes would be to 
obtain shorter chemically synthesized double stranded probes, both labeled and unlabeled, 
containing the suspected binding sequences of ArsR and HP1021 (Table 4). According to 
the manufacturer protocols for the Lightshift® Chemiluminescent EMSA Kit (Thermo), 
EMSA reactions containing probes with 20 – 60 base pairs are optimal. Perhaps 
performing the EMSAs with shorter probes that are professionally purified will resolve 
the challenge of demonstrating specific competition. Additional experiments titrating the 
amount of unlabeled probe required to compete away each shift would provide insight 
into the binding affinity of each suspected binding site with ArsR or HP1021. This 
information would greatly inform our hypothetical models of ArsR and HP1021-
mediated regulation of acxA (Figures 12 and 13) as well as provide insight into the nature 
of competition between ArsR and HP1021 for specific binding sequences. 
 Additional experiments must be conducted to determine the mechanistic role of the 
three suspected HP1021 binding sites present near or within the coding region of acxA. 
Transcriptional profiling experiments have identified HP1021 as a transcriptional 
activator of acxA expression (Pflock et al., 2007a), and it is not typical of transcriptional 
activators to bind within the coding sequence of a gene. The hypothetical negative 
regulatory function these binding sites may serve to prevent overexpression of acxA in 
the case of high HP1021 concentrations is posited in Figure 13, but this hypothesis 
remains to be tested. A previous study by Mueller et al. sought to determine the impact of 
overexpression of HP1021 on the growth of H. pylori by creating strains merodiploid for 
hp1021, however no overt phenotype was observed (Mueller et al., 2007). Obtaining 
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hp1021 merodiploid strains and assaying for the expression of acxA and hp1021 using 
qPCR would allow for the correlation of acxA transcription with hp1021 transcription, 
providing an experimental means to test our existing hypothetical model. Generating 
hp1021 merodiploid mutants in multiple strains of H. pylori would also afford inter-strain 
comparisons similar to our study of ArsRS-mediated regulation of acxA in H. pylori 
strains 26695 and J99. 
 
 
Figure 14. qPCR of H. pylori strains grown at pH 7. This figure shows the relative 
expression of acxA in 26695 and J99 arsS null mutants relative to their corresponding 
wild-type strains. The error bars represent the RQmin and RQmax calculated to a 95% 
confidence interval. These strains were grown under neutral pH conditions. The data 
represents results from triplicate samples from a single experiment. Similar results were 
obtained from three experiments.  
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Figure 15. qPCR of H. pylori strains grown at pH 5. This figure shows the relative 
expression of acxA in 26695 and J99 arsS null mutants relative to their corresponding 
wild-type strains. The error bars represent the RQmin and RQmax calculated to a 95% 
confidence interval. These strains were grown under neutral pH conditions. The data 
represents results from triplicate samples from a single experiment. Similar results were 
obtained from three experiments.  
 
3.8 - Concluding Thoughts 
 Combined with previous studies of ArsR and HP1021, the data in this study 
supports direct regulation of acxABC transcription by the binding of ArsR and HP1021 to 
the acxA promoter as well as the coding region of the gene. Localization of the binding 
sites of ArsR and HP1021 indicates the presence of two binding sites for ArsR and six 
sites for HP1021. ArsR and HP1021 bind sites that are very close to one another and may 
overlap, suggesting that H. pylori utilizes multiple competing TCSTs to fine-tune the 
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expression of acxA. ArsRS-mediated regulation of acxA occurs at the transcriptional level, 
and variation in this regulation exists between H. pylori strains J99 and 26695.  
 Unpublished data from our lab also suggests that CrdR binds directly to the 
promoter of acxA, and FlgR may interact with the promoter region through an unknown 
cofactor (Quinlivan-Repasi et al., 2011 - unpublished). Along with this study, that data 
provides evidence for the physical interaction of all H. pylori TCSTs with the acxA 
promoter. While characterizing the precise mechanism of acxA regulation for these 
TCSTs will require further study, these results demonstrate the value of acxA as a model 
for understanding multiple TCST regulatory mechanisms converging on a single gene. 
The regulation of acxA is also an excellent example of how H. pylori, a bacterium with 
few regulatory systems, can precisely regulate gene expression. Other H. pylori virulence 
and survival genes that are subject to TCST regulation may be regulated in a similar 
manner. The presence of such a layered and complex mechanism of control over acxABC 
identifies the potential critical nature of acetone carboxylase expression in H. pylori 
physiology. Strain-specific differences in the regulation of acetone carboxylase add 
another layer of complexity in understanding the varied clinical outcomes associated with 
H. pylori infection. Combined with animal studies demonstrating the importance of 
acxABC in colonization and the establishment of infection (Brahmachary et al., 2008), 
these results highlight the acetone carboxylase operon as an important H. pylori virulence 
factor and nexus of TCST-mediated gene regulation that is worthy of future study. 
  
	   51	  
4 - References 
Alm, R., Ling, L., Moir, D., King, B., Brown, E., Doig, P., Smith, D., Noonan, B., Guild, 
B., deJonge, B., Carmel, G., Tummino, P., Caruso, A., Uria-Nickelsen, M., Mills, 
D., Ives, C., Gibson, R., Merberg, D., Mills, S., Jiang, Q., Taylor, D., Vovis, G., 
& Trost, T. (1999). Genomic-sequence comparison of two unrelated isolates of 
the human gastric pathogen Helicobacter pylori. Nature, 397(6715), 176-180. 
Beier, D., Spohn, G., Rappuoli, R., & Scarlato, V. (1997). Identification and 
characterization of an operon of Helicobacter pylori that is involved in motility 
and stress adaptation. Journal of Bacteriology, 179(15), 4676-4683. 
Beier, D., & Frank, R. (2000). Molecular characterization of two-component systems of 
Helicobacter pylori. Journal of Bacteriology, 182(8), 2068-2076. 
Blaser, M., Perezperez, G., Kleanthous, H., Cover, T., Peek, R., Chyou, P., 
Stemmermann, G., & Nomura, A. (1995). Infection with Helicobacter pylori 
strains possessing caga is associated with an increased risk of developing 
adenocarcinoma of the stomach. Cancer Research, 55(10), 2111-2115. 
Bourret, R. B., & Silversmith, R. E. (2010). Two-component signal transduction. Current 
Opinion in Microbiology, 13(2), 113-115. 
Brahmachary, P., Dashti, M., Olson, J., & Hoover, T. (2004). Helicobacter pylori FlgR is 
an enhancer-independent activator of sigma(54)-RNA polymerase holoenzyme. 
Journal of Bacteriology, 186(14), 4535-4542. 
Brahmachary, P., Wang, G., Benoit, S. L., Weinberg, M. V., Maier, R. J., & Hoover, T. R. 
(2008). The human gastric pathogen Helicobacter pylori has a potential acetone 
carboxylase that enhances its ability to colonize mice. Bmc Microbiology, 8, 14. 
Brown, L. (2000). Helicobacter pylori: Epidemiology and routes of transmission. 
Epidemiologic Reviews, 22(2), 283-297. 
Corthésy-Theulaz, I., Bergonzelli, G., Henry, H., Bachmann, D., Schorderet, D., Blum, 
A., & Ornston, L. (1997). Cloning and characterization of Helicobacter pylori 
succinyl CoA:Acetoacetate CoA-transferase, a novel prokaryotic member of the 
CoA-transferase family. Journal of Biological Chemistry, 272(41), 25659-25667. 
Cover, T., & Blaser, M. (1992). Purification and characterization of the vacuolating toxin 
from Helicobacter pylori. Journal of Biological Chemistry, 267(15), 10570-10575. 
	   52	  
Danielli, A., Amore, G., & Scarlato, V. (2010). Built shallow to maintain homeostasis 
and persistent infection: Insight into the transcriptional regulatory network of the 
gastric human pathogen Helicobacter pylori. Plos Pathogens, 6(6), e1000938. 
Dunn, B., Cohen, H., & Blaser, M. (1997). Helicobacter pylori. Clinical Microbiology 
Reviews, 10(4), 720-&. 
Eaton, K., Suerbaum, S., Josenhans, C., & Krakowka, S. (1996). Colonization of 
gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. 
Infection and Immunity, 64(7), 2445-2448. 
El-Omar, E. (2001). The importance of interleukin 1 beta in Helicobacter pylori 
associated disease. Gut, 48(6), 743-747. 
Forsyth, M., Cao, P., Garcia, P., Hall, J., & Cover, T. (2002). Genome-wide 
transcriptional profiling in a histidine kinase mutant of Helicobacter pylori 
identifies members of a regulon. Journal of Bacteriology, 184(16), 4630-4635. 
Forsyth, M., & Cover, T. (1999). Mutational analysis of the vacA promoter provides 
insight into gene transcription in Helicobacter pylori. Journal of Bacteriology, 
181(7), 2261-2266. 
Garber, A., Menzel, P., Boden, G., & Owen, O. (1974). Hepatic ketogenesis and 
gluconeogenesis in humans. Journal of Clinical Investigation, 54(4), 981-989. 
Gotoh, Y., Eguchi, Y., Watanabe, T., Okamoto, S., Doi, A., & Utsumi, R. (2010). Two-
component signal transduction as potential drug targets in pathogenic bacteria. 
Current Opinion in Microbiology, 13(2), 232-239. 
Gupta, S. S., Borin, B. N., Cover, T. L., & Krezel, A. M. (2009). Structural analysis of 
the DNA-binding domain of the Helicobacter pylori response regulator ArsR. 
Journal of Biological Chemistry, 284(10), 6536-6545. 
Holcombe, C. (1992). Helicobacter pylori - the african enigma. Gut, 33(4), 429-431. 
Kim, D., & Forst, S. (2001). Genomic analysis of the histidine kinase family in bacteria 
and archaea. Microbiology-Sgm, 147, 1197-1212. 
Laub, M. T., & Goulian, M. (2007). Specificity in two-component signal transduction 
pathways. Annual Review of Genetics, 41, 121-145. 
Liu, Z., Xu, X., Chen, L., Li, W., Sun, Y., Zeng, J., Yu, H., Chen, C., & Jia, J. (2012). 
Helicobacter pylori CagA inhibits the expression of Runx3 via Src/MEK/ERK 
and p38 MAPK pathways in gastric epithelial cell. Journal of Cellular 
Biochemistry, 113(3), 1080-1086. 
	   53	  
Loh, J. T., Gupta, S. S., Friedman, D. B., Krezel, A. M., & Cover, T. L. (2010). Analysis 
of protein expression regulated by the Helicobacter pylori ArsRS two-component 
signal transduction system. Journal of Bacteriology, 192(8), 2034-2043. 
Loh, J., & Cover, T. (2006). Requirement of histidine kinases HP0165 and HP1364 for 
acid resistance in Helicobacter pylori. Infection and Immunity, 74(5), 3052-3059. 
Markowsky, A., Kim, D., Cao, P., Cover, T., Forsyth, M. (2004) Unpublished Data. The 
College of William and Mary. 
Marshall, B., & Warren, J. (1984). Unidentified curved bacilli in the stomach of patients 
with gastritis and peptic-ulceration. Lancet, 1(8390), 1311-1315. 
McNulty, S., Mole, B., Dailidiene, D., Segal, I., Ally, R., Mistry, R., Secka, O., Adegbola, 
R., Thomas, J., Lenarcic, E., Peek, R., Berg, D., & Forsyth, M. (2004). Novel 
180- and 480-base-pair insertions in african and african-american strains of 
Helicobacter pylori. Journal of Clinical Microbiology, 42(12), 5658-5663. 
Merrell, D., Goodrich, M., Otto, G., Tompkins, L., & Falkow, S. (2003). pH-regulated 
gene expression of the gastric pathogen Helicobacter pylori RID A-5919-2009. 
Infection and Immunity, 71(6), 3529-3539. 
Miwa, H., Go, M., & Sato, N. (2002). H. pylori and gastric cancer: The asian enigma. 
American Journal of Gastroenterology, 97(5), 1106-1112. 
Mueller, S., Pflock, M., Schaer, J., Kennard, S., & Beier, D. (2007). Regulation of 
expression of atypical orphan response regulators of Helicobacter pylori. 
Microbiological Research, 162(1), 1-14. 
Ohnishi, N., Yuasa, H., Tanaka, S., Sawa, H., Miura, M., Matsui, A., Higashi, H., 
Musashi, M., Lwabuchi, K., Suzuki, M., Yamada, G., Azuma, T., & Hatakeyama, 
M. (2008). Transgenic expression of Helicobacter pylori CagA induces 
gastrointestinal and hematopoietic neoplasms in mouse RID D-3586-2011. 
Proceedings of the National Academy of Sciences of the United States of America, 
105(3), 1003-1008. 
Panthel, K., Dietz, P., Haas, R., & Beier, D. (2003). Two-component systems of 
Helicobacter pylori contribute to virulence in a mouse infection model. Infection 
and Immunity, 71(9), 5381-5385. 
Parkin, D. (2001). Global cancer statistics in the year 2000. Lancet Oncology, 2(9), 533-
543. 
Pflock, M., Kennard, S., Delany, I., Scarlato, V., & Beier, D. (2005). Acid-induced 
activation of the urease promoters is mediated directly by the ArsRS two-
	   54	  
component system of Helicobacter pylori. Infection and Immunity, 73(10), 6437-
6445. 
Pflock, M., Bathon, M., Schaer, J., Mueller, S., Mollenkopf, H., Meyer, T. F., & Beier, D. 
(2007a). The orphan response regulator HP1021 of Helicobacter pylori regulates 
transcription of a gene cluster presumably involved in acetone metabolism. 
Journal of Bacteriology, 189(6), 2339-2349. 
Pflock, M., Finsterer, N., Joseph, B., Mollenkop, H., Meyer, T. F., & Beier, D. (2006). 
Characterization of the ArsRS regulon of Helicobacter pylori, involved in acid 
adaptation. Journal of Bacteriology, 188(10), 3449-3462. 
Pflock, M., Mueller, S., & Beier, D. (2007b). The CrdRS (HP1365-HP1364) two-
component system is not involved in pH-responsive gene regulation in the 
Helicobacter pylori strains 26695 and G27. Current Microbiology, 54(4), 320-324. 
Quinlivan-Repasi, V., Harvey, S., Forsyth, M. (2004). Unpublished Data. The College of 
William and Mary. 
Sambrook, J., & Russell, D.W. Molecular Cloning: a Laboratory Manual. Cold Spring 
Harbor Press, 2001. 
Schar, J., Sickmann, A., & Beier, D. (2005). Phosphorylation-independent activity of 
atypical response regulators of Helicobacter pylori RID A-1010-2011. Journal of 
Bacteriology, 187(9), 3100-3109. 
Scott, D., Marcus, E., Weeks, D., & Sachs, G. (2002). Mechanisms of. acid resistance 
due to the urease system of Helicobacter pylori. Gastroenterology, 123(1), 187-
195. 
Sharma, C. M., Hoffmann, S., Darfeuille, F., Reignier, J., Findeiss, S., Sittka, A., Chabas, 
S., Reiche, K., Hackermueller, J., Reinhardt, R., Stadler, P. F., & Vogel, J. (2010). 
The primary transcriptome of the major human pathogen Helicobacter pylori RID 
D-5574-2011. Nature, 464(7286), 250-255. 
Tomb, J., White, O., Kerlavage, A., Clayton, R., Sutton, G., Fleischmann, R., Ketchum, 
K., Klenk, H., Gill, S., Dougherty, B., Nelson, K., Quackenbush, J., Zhou, L., 
Kirkness, E., Peterson, S., Loftus, B., Richardson, D., Dodson, R., Khalak, H., 
Glodek, A., McKenney, K., Fitzgerald, L., Lee, N., Adams, M., Hickey, E., Berg, 
D., Gocayne, J., Utterback, T., Peterson, J., Kelley, J., Cotton, M., Weldman, J., 
Fujii, C., Bowman, C., Watthey, L., Wallin, E., Hayes, W., Weldman, J., 
Borodovsky, M., Karp, P., Smith, H., Fraser, C., & Venter, J. (1997). The 
complete genome sequence of the gastric pathogen Helicobacter pylori. Nature, 
388(6642), 539-547. 
	   55	  
Vogiatzi, P., Cassone, M., Luzzi, I., Lucchetti, C., Otvos, L., Jr., & Giordano, A. (2007). 
Helicobacter pylori as a class I carcinogen: Physiopathology and management 
strategies RID F-1927-2010. Journal of Cellular Biochemistry, 102(2), 264-273. 
Waidner, B., Melchers, M., Stahler, F., Kist, M., & Bereswill, S. (2005). The 
Helicobacter pylori CrdRS two-component regulation system (HP1364/HP1365) 
is required for copper-mediated induction of the copper resistance determinant 
CrdA. Journal of Bacteriology, 187(13), 4683-4688. 
Wang, H., Han, J., Chen, D., Duan, X., Gao, X., Wang, X., & Shao, S. (2012). 
Characterization of CagI in the cag pathogenicity island of Helicobacter pylori. 
Current Microbiology, 64(2), 191-196. 
Wen, Y., Feng, J., Scott, D., Marcus, E., & Sachs, G. (2006). Involvement of the 
HP0165-HP0166 two-component system in expression of some acidic-pH-
upregulated genes of Helicobacter pylori. Journal of Bacteriology, 188(5), 1750-
1761. 
Wen, Y., Feng, J., Scott, D. R., Marcus, E. A., & Sachs, G. (2008). Hp0244 (FLGS) is an 
essential cytoplasmic pH sensor for Helicobacter pylori acid adaptation. 
Gastroenterology, 134(4), A85-A85. 
Wen, Y., Feng, J., Scott, D. R., Marcus, E. A., & Sachs, G. (2009). The pH-responsive 
regulon of HP0244 (FlgS), the cytoplasmic histidine kinase of Helicobacter pylori. 
Journal of Bacteriology, 191(2), 449-460. 
Wen, Y., Marcus, E., Matrubutham, U., Gleeson, M., Scott, D., & Sachs, G. (2003). 
Acid-adaptive genes of Helicobacter pylori. Infection and Immunity, 71(10), 
5921-5939. 
Wirth, T., Wang, X., Linz, B., Novick, R., Lum, J., Blaser, M., Morelli, G., Falush, D., & 
Achtman, M. (2004). Distinguishing human ethnic groups by means of sequences 
from Helicobacter pylori: Lessons from ladakh RID B-4915-2008. Proceedings of 
the National Academy of Sciences of the United States of America, 101(14), 
4746-4751. 
Wroblewski, L. E., Peek, R. M., Jr., & Wilson, K. T. (2010). Helicobacter pylori and 
gastric cancer: Factors that modulate disease risk. Clinical Microbiology Reviews, 
23(4), 713-739. 
Yamaoka, Y., Ojo, O., Fujimoto, S., Odenbreit, S., Haas, R., Gutierrez, O., T El-Zimaity, 
H., Reddy, R., Amqvist, A., & Graham, D. (2006). Helicobacter pylori outer 
membrane proteins and gastroduodenal disease. Gut, 55(6), 775-781. 
